Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons

Richard J. Konkol, Richard B. Mailman, Elizabeth G. Bendeich, A. Marcine Garrison, Robert A. Mueller, George R. Breese

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Intracisternal NGF or anti-NGF has been found to produce no long-term major alterations in central norepinephrine (NE) or dopamine levels when administered to neonatal rats. While NGF and anti-NGF were found to produce significant changes in brain NE content within one week of treatment, changes in central NE were no longer detectable at 30 days of age. Modification of the growth response of the central adrenergic neurons following 6-OHDA treatment was also not affected by NGF or anti-NGF when evaluated 3 weeks after treatment. However, centrally administered anti-NGF did induce a loss of peripheral NE terminals, which was attributed to leakage of the anti-NGF from the central injection site.

Original languageEnglish (US)
Pages (from-to)277-285
Number of pages9
JournalBrain research
Volume144
Issue number2
DOIs
StatePublished - Apr 14 1978

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint Dive into the research topics of 'Evaluation of the effects of nerve growth factor and anti-nerve growth factor on the development of central catecholamine-containing neurons'. Together they form a unique fingerprint.

  • Cite this